DSIP
Purity
≥98%
Batch No.
Shelf Life
24 months
Delta Sleep-Inducing Peptide (DSIP) — a naturally occurring nonapeptide first isolated from rabbit cerebral venous blood, studied for its modulatory effects on sleep architecture and neuroendocrine function.
Select Size
Research Use Only. This product is intended for in-vitro research and laboratory use only. Not for human or veterinary consumption. By purchasing, you confirm you are a qualified researcher.
Frequently Bought With
Researchers who purchased DSIP also bought
Ancillaries
Bacteriostatic Water
Pharmaceutical-grade bacteriostatic water (0.9% benzyl alcohol) for reconstitution of lyophilised research peptides.
Healing Peptides
GHK-Cu
Copper peptide GHK-Cu — a naturally occurring tripeptide with extensive research into wound healing and skin biology.
Independent research only. The studies listed below are published by independent researchers and institutions. They are provided for reference purposes only and are entirely independent of PGNA Labs. PGNA Labs makes no claims based on these studies. All products are supplied strictly for research use and are not intended for human consumption.
Delta-sleep-inducing peptide (DSIP): a review
A comprehensive review of DSIP as a nonapeptide of MW 849, demonstrating its ability to induce delta-sleep in rabbits, rats, mice, and humans. The paper summarises evidence for DSIP's neuroendocrine modulatory effects and its potential as a therapeutic agent for sleep disorders.
Delta-sleep-inducing peptide (DSIP): an update
An updated review evaluating the potential therapeutic use of DSIP for insomnia, pain, and stress-related conditions. The authors summarise advances in understanding DSIP's distribution, metabolism, and receptor interactions since its initial characterisation.
Delta sleep-inducing peptide (DSIP): a still unresolved riddle
A critical review examining the paradoxes surrounding DSIP, including inconsistencies in its sleep-promoting effects across species and experimental conditions. The paper outlines future research directions for clarifying DSIP's physiological role and potential synthesis pathways.
Effects of delta sleep-inducing peptide on sleep of chronic insomniacs
A clinical study in chronic insomniacs showing that DSIP administration resulted in higher sleep efficiency and shorter sleep latency compared to placebo, providing objective polysomnographic evidence for DSIP's sleep-promoting effects in a human clinical population.
Study of delta sleep-inducing peptide efficacy in improving sleep on insomniac patients
Polysomnographic assessment of DSIP in insomniac patients demonstrating improvements in sleep cycle architecture. The study provides early clinical evidence for DSIP's efficacy in modulating sleep quality in patients with established sleep disturbances.
Links open in a new tab. PGNA Labs is not affiliated with any of the linked publications.
Related Peptides
You May Also Like
Semax
Heptapeptide analogue of the ACTH(4-7) fragment, researched for neuroprotective and nootropic properties.
£15.00
MOTS-c
Mitochondria-derived peptide researched for metabolic regulation, insulin sensitivity, and exercise capacity.
£16.00
CJC-1295 Without DAC
Modified GRF(1-29) — a growth hormone releasing hormone analogue without the Drug Affinity Complex.
£19.00
We use cookies & local storage
We use essential cookies for authentication and local storage to remember your preferences (theme, cart). We also use analytics to understand how the site is used. By clicking Accept, you consent to non-essential cookies and analytics. You can read our Privacy Policy for full details.